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Neurohypophysial oxytocin (OT) and vasopressin (VP) genes are transcribed in thymic epithelium,
while immature T lymphocytes express functional neurohypophysial receptors. Neurohypophysial
receptors belong to the G protein-linked seven-transmembrane receptor superfamily and are encoded
by four distinct genes, OTR, V1R,V2R andV3R. The objective of this study was to identify the nature of
neurohypophysial receptor in thymic T cell subsets puriﬁed by immunomagnetic selection, as well as in
murine thymic lymphoma cell lines RL12-NP and BW5147. OTR is transcribed in all thymic T cell
subsets and T cell lines, while V3R transcription is restricted to CD4
þCD8
þ and CD8
þ thymic cells.
Neither V1R nor V2R transcripts are detected in any kind of T cells. The OTR protein was identiﬁed by
immunocytochemistry on thymocytes freshly isolated from C57BL/6 mice. In murine fetal thymic
organ cultures, a speciﬁc OTR antagonist does not modify the percentage of T cell subsets, but
increases late T cell apoptosis further evidencing the involvement of OT/OTR signaling in the control
of T cell proliferation and survival. According to these data, OTR and V3R are differentially expressed
during T cell ontogeny. Moreover, the restriction of OTR transcription to T cell lines derived from
thymic lymphomas may be important in the context of T cell leukemia pathogenesis and treatment.
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INTRODUCTION
A repertoire of neuroendocrine-related genes are expressed
withinthethymusparenchymeofdifferentspecies(Martens
et al., 1996). Thymic neuroendocrine-related genes are
highly conserved throughout evolution of their family and
one dominant member is expressed in the thymus network:
insulin-like growth factor 2 (IGF2) for the insulin family,
neurokinin A (NKA) for tachykinins (Ericsson et al.,1 9 9 0 ) ,
and neurotensin (NT) for neuromedins (Vanneste et al.,
1997). Thymic precursors encoded by these genes exert a
dualroleinTcelldifferentiationaccordingtotheirbehavior
eitherascryptocrine/juxtacrineligandsorasneuroendocrine
self-antigens (Geenen et al., 1999; Geenen et al.,i np r e s s ) .
With regard to the neurohypophysial gene family, both
oxytocin (OT) and vasopressin (VP) genes are expressed
in thymic epithelial and nurse cells (TEC/TNC) from
different species. At the peptide level however, thymic OT
concentration is much higher than VP (Robert et al.,1 9 9 2 ;
Geenen et al., 1998). During mouse ontogeny, OT and VP
expression starts in thymic epithelium on embryonic day
E13, while neurohypophysial transcripts are evidenced
inthebrainonlyonE15(submittedforpublication).Speciﬁc
OT and VP binding sites have been evidenced in the rat
thymus (Elands et al., 1990), as well as on a murine
CD4
2CD8
2 T cell line (RL12-NP) derived from X ray-
induced thymic lymphoma in C57BL/Ka mice (Martens
et al., 1992). These binding sites function as true receptors
and are able to transduce neurohypophysial ligands into
phosphoinositide turnover followed by proliferation effects
(Martens et al., 1992). More speciﬁcally, neurohypophysial
peptides, and OT in particular, markedly stimulate the
phosphorylationoffocaladhesionkinasesinRL12-NPcells
(Martens et al.,1 9 9 8 ) .
Distinct genes (OTR, V1R, V2R and V3R) encode four
neurohypophysialpeptidereceptorswhichallbelongtothe
superfamily of G-coupled seven-transmembrane proteins.
OTR is primarily expressed in uterus myometrium, V1R in
vascularsmoothmuscleandendotheliumaswellasinliver
epithelial cells, V2R in the epithelium of kidney water
collecting tubules, and V3R in anterior pituitary cortico-
troph cells (Gainer and Wray, 1994). OTR, V1R and V3R
are coupled to protein Gq/11 and activate phospholipase C
pathway(Thibonnieretal.,1993),whileV2Riscoupledto
protein Gs and activates adenylate cyclase pathway
(Barberis and Tribollet, 1996).
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Clinical & Developmental Immunology, March 2004, Vol. 11 (1), pp. 45–51This study aimed todeterminethe nature and distribution
of OTR, V1R, V2R and V3R expressed by murine thymic
T cell subpopulations and by thymic lymphoma-derived T
celllines RL12-NPandBW5147.Inaddition,apreliminary
insight into the functional role played by the thymic
neurohypophysial axis in T cell development was
investigated through the use of fetal thymic organ cultures
(FTOC) (Jenkinson and Anderson, 1994).
RESULTS
Neurohypophysial Receptor Expression
OTR Expression
RT-PCR with OTR speciﬁc primers revealed the presence
of a 273-bp product in the mouse uterus as positive
control. A same sized RT-PCR product was detected in all
thymic T cell subsets, and in RL12-NP and BW5147 lines
(Fig. 1A). Southern blotting of the PCR product and
hybridization with a speciﬁc probe conﬁrmed the presence
of OTR transcripts in thymocytes (Fig. 1B). Further
sequencing of the 237-bp product ampliﬁed from RL2-NP
cells showed a 97.1% homology with murine OTR
sequence. Thymocytes freshly isolated from C57BL/6
mice were also positively stained with a speciﬁc Ab to
OTR (Fig. 1C).
V3R Expression
RT-PCR with V3R primers identiﬁed a 254-bp product in
mouse anterior pituitary as positive control. A same sized
product was similarly detected in thymic CD4
þCD8
þ and
CD8
þ T cells, but neither in CD4
2CD8
2 nor in CD4
þ
T cells (Fig. 2A). No ampliﬁed product was detected in
RL12-NP and BW5147 lines (not shown). Southern
blotting and hybridization with a speciﬁc probe conﬁrmed
V3R expression in CD4
þCD8
þ and CD8
þ thymic T cells
(Fig. 2B).
FIGURE 1 OTR expression. (A) RT-PCR in murine T cell subsets and lymphoid T cell lines; C 2 : negative control; MM: molecular mass marker;
C þ : positive control; DN: CD4
2CD8
2; DP: CD4
þCD8
þ; CD4: CD4
þ; CD8: CD8
þ; RL: CD4
2CD8
2 lymphoid RL12-NP T cell line; BW:
CD4
2CD8
2 lymphoid BW5147 T cell line. (B) Southern-blotting in thymocytes (T) and lymphoid T cell lines (RL, BW). (C) Immunocytochemistry on
freshly isolated thymocytes. 1: negative control; 2: anti-OTR antibody. Magniﬁcation, £ 400.
FIGURE 2 V3R expression. (A) RT-PCR in murine T cell subsets. (B) Southern blotting in murine T cell subsets. See Fig. 1 legend for abbreviations.
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RT-PCR with V1R and V2R primers revealed the presence
of 409 and 437-bp products in liver and kidney,
respectively, but failed to amplify any product in thymic
T cells and T cell lines. Hybridization with speciﬁc probes
conﬁrmed the absence of V1R and V2R transcripts in all
T cell samples (data not shown).
Effects of Neurohypophysial Receptor Antagonists on
T Cell Differentiation and Survival in FTOC
From day 0 (corresponding to E14) to day 6 of FTOC,
RT-PCR with OT and VP speciﬁc forward and reverse
primers revealed 211 and 188-bp products, respectively,
which hybridized with speciﬁc OT and VP oligonucleo-
tide probes after membrane transfer. In FTOC treated
with speciﬁc OTR and V1R antagonists at 10
26 and
10
29M, no signiﬁcant effect could be observed on T cell
differentiation. However, the OTR antagonist (10
26 and
10
29M)—but not the V1R antagonist—induced a
signiﬁcant increase of late apoptosis parameters (Fig. 3).
DISCUSSION
As suggested by previous studies (Torres and Johnson,
1988; Elands et al., 1990; Martens et al., 1992),
T lymphocytes express neurohypophysial peptide
receptors, but the precise identity of receptor subtypes
and positive T cells still had to be fully characterized.
The present study addressed this question by investigating
the nature of neurohypophysial receptor expressed by
highly puriﬁed thymic T cells and by thymic lymphoma-
derived T cell lines RL12-NP and BW5147. As clearly
shown, OTR is transcribed in all MACS-puriﬁed thymic
T cell subsets (CD4
2CD8
2, CD4
þCD8
þ, CD4
þ and
CD8
þ), as well as in RL12-NP and BW5147 T cell
lines. OTR transcription leads to membrane expression
of the OTR protein in freshly isolated thymocytes.
These data conﬁrm at the molecular level those
previously obtained by autoradiography and by classic
radio-ligand binding analyses (Elands et al., 1990;
Martens et al., 1992).
RT-PCR with V3R primers identiﬁed in CD4
þCD8
þ
and CD8
þ cells a product with the same size as the
anterior pituitary positive control. Southern blotting and
hybridization with a speciﬁc probe conﬁrmed that V3R is
expressed by these T cell subpopulations. This result
indicates that V3R might be the other neurohypophysial
receptor expressed by T cells as already suggested in a
previous study (Martens et al., 1992). Our observation
also explains the positive hybridization with V3R cDNA
in northern blots from human thymus extracts (Sugimoto
et al., 1994). Nevertheless, we cannot deﬁnitively exclude
that other cell types might also express V3R in the thymus
cellular network.
FIGURE 3 (A) Percentage of T cell subsets collected from FTOC after treatment with OTR and V1R antagonists. (B) Staining with apoptosis markers
of isolated thymocytes from FTOC after treatment by OTR and V1R antagonists; A þ PI 2 : early apoptosis cells; A þ PI þ : late apoptosis cells;
A 2 PI 2 : living cells. Each column represents percentage ðm ^ dsÞ of variation by comparison with basal conditions (100%). *p , 0.05; **p , 0.01.
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T cell types investigated. Since vascular endothelial cells
express this receptor (Barberis and Tribollet, 1996;
Zingg, 1996), this negative result indirectly conﬁrms that
our puriﬁcation procedure is not contaminated
by endothelial cells. V2R expression was neither
observed in any type of T cells and this concords with
our experience about the absence of adenylate
cyclase activation by neurohypophysial-related peptides
in immature or mature T cells. Previously, a radio-
binding study had suggested that, in the immune system,
only macrophages express the V2R type of neurohypo-
physial receptor (Block et al., 1981).
The functional role of thymic neurohypophysial-related
peptides must be discussed according to the behavior of
the ﬁnal peptide product processed in TEC following OT
and VP transcription. This study characterizes the
parameters involved in the signaling between neurohypo-
physial ligands and receptors, and these may be currently
deﬁned as follows. At the level of the neurohypophysial
ligands, both OT and VP peptides are synthesized in
thymic epithelial cells (TEC), with a dominance of OT.
At the level of the receptors, OTR is expressed at all main
stages of T cell differentiation, while V3R expression is
restricted to CD4
þCD8
þ and CD8
þ T cells. Thus, a
different pattern of neurohypophysial receptor expression
occurs along with the process of T cell differentiation.
Similarly to what has been shown for IGF type 2 receptors
(CD222) (Mason, 2000), it may be expected that OTR and
V3R also will be soon identiﬁed as new cluster
differentiation (CD) markers. Ancient studies have
reported that neurohypophysial ligands increase thymo-
cyte growth (Whitﬁeld et al., 1969; Martens et al., 1992)
and the level of glucose oxydation in the thymus (Goren
et al., 1984). More recently, the binding of neurohypo-
physial ligands, particularly OT, was shown to increase
the level of inositol triphosphate and to phosphorylate
focal adhesion-related kinases (FAK) in immature T cells
(Martens et al., 1992, 1998). The implication of these
kinases in T cell differentiation has also been described by
other authors (Kanazawa et al., 1996). In this study, the
FTOC model was used to gain a ﬁrst insight into the role
of the thymic neurohypophysial axis in T cell develop-
ment. Endogenous OT and VP transcription was controlled
throughout FTOC duration. FTOC treatment with a
speciﬁc OTR antagonist (10
26 and 10
29M) induced a
signiﬁcant increase in late apoptosis parameters, but did
not modify the percentage of T cell subsets. A V1R
antagonist did not exert any signiﬁcant inﬂuence, in
accordance with the absence of V1R expression by thymic
T cell subsets. These data further conﬁrm that an
intrathymic OT/OTR signaling is implicated in the
general process of T cell development and survival.
Since this pathway also controls FAK phosphorylation in
CD4
2CD8
2 RL12-NP cells, thymic OT/OTR signaling
could play a signiﬁcant role in the promotion of
immunological synapses between TEC and thymocytes
during T cell differentiation.
Finally, it should be stressed that the investigation
of neurohypophysial receptor expression by immature
CD4
2CD8
2 T cells lines derived from murine thymic
lymphomas showed that OTR is the only neuro-
hypophysial receptor expressed by those cells.
With regard to the mitogenic and FAK-promoting activity
of thymic OT, as well as proapoptotic properties of
the OTR antagonist, this ﬁnding suggests that the use of
OTR antagonist might be considered in the future therapy
of T cell lymphomas/leukemia’s.
MATERIALS AND METHODS
Cell Lines and Reagents
Immature T cell lines are RL12-NP derived from X ray-
induced thymic lymphoid tumor in C57BL/Ka mice
(Lieberman et al., 1979) and BW5147, established from
radio-induced thymic lymphoma in female C57BL/6
(Vink et al., 1993). These T cell lines exhibit an immature
CD4
2CD8
2 phenotype. Polyclonal Ab to OTR was
kindly gifted by Paola Cassoni (University of Torino,
Italy) (Bussolati et al., 1996). The OTR antagonist
des-Gly-NH2d(CH2)2[D-Tyr
2,T h r
4]OVT), and the
V1R antagonist d(CH2)5-Tyr(Me)AVP were kindly
provided by Maurice Manning (Medical College of
Ohio, Toledo, OH).
Staining and Immunomagnetic Separation (MACS)
Thymic lobes were surgically removed from adult
female C57BL/6 mice; they were cut in small pieces,
ﬁltered and washed in DPBS buffer. Thymocyte suspen-
sion was incubated with a mAb cocktail prepared for
negative selection of CD4 and CD8 T cells (StemCell
Technologies). After washing in DPBS buffer, an
anti-biotin tetrameric Ab complex mix (StemCell
Technologies) was added. The last incubation was
performed with a magnetic colloid (StemCell Technol-
ogies). Separation was realized with a MACS column
(Miltenyi Biotec).
FTOC
Fetal thymic lobes were removed from Balb/c murine
embryos on E14, the day 0 being the day of vaginal
plug observation. Thymic lobes were cultured on a
Nucleopore ﬁlter (Corning), put on a sterile sponge
(Gelfoam), as previously described (Kecha et al., 2000).
Culture medium was Iscove ﬁltered Medium modiﬁed
by the Dulbecco’s Method (IMDM, Cambrex), enriched
with L-glutamin (2mM), HEPES (10mM), non essential
amino acids (1%), natrium pyruvate (1mM), penicillin
(50IU/ml), streptomycin (50ng/ml) and 10% fetal
bovine serum (Life Technologies).
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Double staining was achieved on FTOC T cells with
anti-CD4 coupled to phycoerythrin (PE) (clone GK 1.5),
andanti-CD8coupledtoﬂuorescein(FITC)(clone53-6.7).
Apoptosis markers were FITC-annexin V (Biosource) and
propidium iodide (PI) (Sigma). Quadruple stainings
were realized with anti-CD4 Ab (PE), biotinylated
(Biot) anti-CD8 Ab followed by Per-CP-coupled strepta-
vidin (PerCP) (Becton-Dickinson), FITC-Annexin
V (Biosource) and PI (Sigma).
Total RNA Extraction
Total RNA from murine uterus, liver, kidney and anterior
pituitary was extracted with TriPure Isolation Reagent
(Boerhinger Mannheim). Total RNA from thymocytes,
cell lines and fetal thymic lobes (at different days of
culture) was extracted with RNeasy Mini Kit (Qiagen).
They were treated (15min, 378C) with DNase I
(5IU/reaction) in presence of RNase inhibitor (2IU/ml).
Reaction was ended by enzyme inactivation (8min, 858C).
Then, 0.1vol NaAc (3M) and 2.5vol ethanol (100%) were
added and RNAwas precipitated (12h, 2208C). After two
washings with ethanol (70%), RNA was suspended in
milli-Q quality water and quantiﬁed with Ribogreen RNA
Quantitation Kit (Molecular Probes).
RT-PCR
Primers were designed from murine OTR, V1R, V2R, V3R,
OT and VP sequences and selected in different exons in
order to exclude genomic DNA from ampliﬁcation. The
sequences of the primers are:
OTR forward: 50-CTGGGACGTCAATGCGCCCAA-
AGAAG-30 and
OTR reverse: 50-CATGCCGAGGATGGTTGAGAAC-
AGCTC-30 (273-bp product)
V1R forward: 50-TGGTCACGCCTTGTGTCAGCAG-
CGTGA-30 and
V1R reverse: 50-GATTTAGGTGAATCCTTCCACGT-
CCCA-30 (409-bp product)
V2R forward: 50-CCCTAGGCATTGCTGCCTGCC-30
and
V2R reverse: 50-GAAGCTGGCTGTGGCACAGGAC-
TCATCTTG-30 (437-bp product)
V3R forward: 50-CGGGTCAGCAGCATCAGTACCA-
TCTCC-30 and
V3R reverse: 50-GGAACGTGGCAACAGGTGGCTG-
TTGA-30 (254-bp product)
OT forward: 50-ACCTCGGCCTGCTACATCCAGAA-
30 and
OT reverse: 50-ACTGGCAGGGCGAAGGCAGGTA-
30 (211-bp product)
VP forward: 50-GGCATCTGCTGCAGCGACGAGA-
30 and
VP reverse: 50-TAGACCCGGGGCTTGGCAGAA-30
(188-bp product)
RNA integrity and concentration were controlled by
RT-PCR with primers derived from murine b-actin
sequence (Pleau et al., 1996):
b-actin forward: 50-TAAAGACCTCTATGCCAACA-
CAGT-30 and
b-actin reverse: 50-CACGATGGAGGGGCCGGACT-
CATC-30 (250-bp product).
TotalRNA(50ng)ofeachsamplewasreverse-transcribed
(RT) using random hexamers (30min, 428C). This was
followed by a denaturation step (5min, 948C) and a
polymerase chain reaction (PCR) with 35 cycles (for OTR,
V1R,V2R,OTandVP)or37cycles(forV3R)cycles.Foreach
cycle, denaturation was 948C for 45s (OT and VP)o r1m i n
(OTR,V1R,V2RandV3R);primerhybridizationwas1minat
548C( b-actin), 568C( OTR, V1R and V2R), 648C( V3R)a n d
45sat668C( OT andVP); elongation phase was 1min (OTR,
V1R, V2R, V3R), or 1min 30s, (OT and VP)a t7 2 8C. After
ampliﬁcation,anadditionalextensionstepat728Cfor10min
was performed. RT-PCR products were analyzed on 2%
agarose gel and stained with ethidium bromide (0.5mg/ml).
Positive controls were RNA from adult Balb/c uterus
(OTR), liver (V1R), kidney (V2R) and anterior pituitary
(V3R). Milli-Q quality water was used as negative control.
Southern Blotting
Neurohypophysial receptor RT-PCR products were trans-
ferred for 60min on Hybond-XL membrane (Amersham,
Pharmacia Biotech), and neurohypophysial ligand RT-PCR
products on Gene Screen Plus membrane (Dupont).
Oligonucleotide probes were synthesized from gene
sequence expected to be included in the ampliﬁed products:
OTR:5 0-GAGACGAGCATTAGCAAGAAAAGCAA-
CTCCTCCACC-30,
V1R:5 0-GAAATTGGTATCCCAGACTGACCACAT-
CTGGACGATGAAG-30,
V2R:5 0-CACCAGACTGGCATGTATCTCCCGGAA-
GATAAGAACC-30,
V3R:5 0-AAGCAATGTAGGCCAGCACAATGACA-
AAGGTCATCTTC-30,
OT:5 0-CCCCTGGGCGGCAAGAGGGCTGTGCTG-
GACCTGGATATGC-30,
VP:5 0-CACAGCTGGACGGCCCTGCTCGGGCGCT-
GCTGCTAAGGCT-30.
Oligonucleotides (50ng) were labeled with [g
32P]
dATP (5ml, 4500Ci/mmol) using T4 kinase (7.9IU)
(Pharmacia), then puriﬁed on BIO-RAD Micro Bio-spin
Column P-30 Tris, RNase-Free.
Hybond XL membranes were prehybridized (2h at
658C) in Denhardt solution (5X), SSC (5X) and SDS
(0.5%) followed by hybridization (12h, 658C) in the same
solution with labeled probe (1,000,000cpm/ml). Mem-
branes were successively washed in a SSC solution (2X)
and SDS (0.1%) (5min), SSC (1X) and SDS (0.1%)
(15min), SSC (0.1X) and SDS (0.1%) (10min). Gene
T-CELL NEUROHYPOPHYSIAL RECEPTOR GENES 49Screen Plus membranes were prehybridized (2h, 608C) in
SSC (5X), Na3PO4 (20mM), Denhardt solution (50X),
SDS (7%) and salmon sperm DNA (0.1ng/ml); this was
followed by hybridization (12h, 608C) in prehybridization
solution þ dextran sulfate (20%) with labeled OT
(560,000cpm/ml) or VP (820,000cpm/ml) probe. Mem-
branes were washed in SSC (5X) (30min, 608C) and in
SSC (2X) (30min, 608C). cDNA was visualized with
PhosphorImager after exposition (2h) or by autoradio-
graphy (2708C, 2 day exposition).
Sequencing
RT-PCR products were subcloned in pCR2.1-TOPO
plasmid (Invitrogen) and sequenced using ABI Prism
BigDye Terminator Cycle Sequencing Ready Reaction Kit
protocol (Perkin Elmer).
Immunocytochemistry
Thymocytes were freshly isolated from C57BL/6 mice,
transferred on slides by cytospin centrifugation and ﬁxed
acccording to Robert et al. (1991). OTR polyclonal Ab
(1:50) was used as ﬁrst Ab, and FITC goat anti-mouse Ig
(Jackson, 1:50) was used in second step.
Statistics
Results were expressed as mean (m) ^ standard deviation
(sd) of values after treatment vs basal conditions.
Normality was tested by Kolmogorov–Smirnov test.
Differences between groups were estimated by ANOVA
and analyzed by multi-comparative Student-Newman–
Keuls test.
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